hydralazine
Selected indexed studies
- Genotype-Guided Hydralazine Therapy. (Am J Nephrol, 2020) [PMID:32927458]
- A review on the clinical pharmacokinetics of hydralazine. (Expert Opin Drug Metab Toxicol, 2022) [PMID:36150895]
- Metabolism of hydralazine. (Drug Metab Rev, 1977) [PMID:344023]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Genotype-Guided Hydralazine Therapy. (2020) pubmed
- A review on the clinical pharmacokinetics of hydralazine. (2022) pubmed
- Metabolism of hydralazine. (1977) pubmed
- Hydralazine and Hydrazine Derivatives: Properties, Applications, and Repositioning Potential. (2025) pubmed
- Hydralazine-induced lupus. (2006) pubmed
- Parenteral hydralazine revisited. (1998) pubmed
- Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer. (2014) pubmed
- Drug therapy. Hydralazine. (1976) pubmed
- Hydralazine-induced lupus: maintaining vigilance with increased use in patients with heart failure. (2006) pubmed
- Hydralazine-associated glomerulonephritis. (1985) pubmed